oncgnostics' Series A - II Round

oncgnostics raised a round of funding on February 21, 2017.

oncgnostics aims at the identification and utilization of molecular markers for the early diagnosis of cervical cancer. The concept, applying tumor-specific DNA methylation markers for cancer diagnosi…

Articles about oncgnostics' Series A - II Round: